日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma

长期生存率和生物标志物分析评估新辅助联合辅助治疗瑞拉利单抗(抗LAG3)和纳武利尤单抗(抗PD-1)在可切除黑色素瘤患者中的疗效

Burton, Elizabeth M; Milton, Denái R; Tetzlaff, Michael T; Wani, Khalida; Ross, Merrick I; Postow, Michael A; Lazcano, Rossana; Glitza, Isabella C; Wong, Michael K; Patel, Sapna P; Diab, Adi; Gershenwald, Jeffrey E; McQuade, Jennifer L; Betof Warner, Allison; Prieto, Victor G; Lee, Jeffrey E; Goepfert, Ryan P; Fisher, Sarah B; Song, Addison; Malke, Jared; Simon, Julie M; Ariyan, Charlotte; Torres-Cabala, Carlos A; Davies, Michael A; Lazar, Alexander; Wargo, Jennifer A; Tawbi, Hussein A; Amaria, Rodabe N

Proton Craniospinal Irradiation for Patients With Leptomeningeal Metastasis: A Randomized Clinical Trial

质子颅脊髓照射治疗软脑膜转移患者:一项随机临床试验

Yang, Jonathan T; Yerramilli, Divya; Pentsova, Elena; Wolden, Suzanne; Young, Robert J; Correa, Denise D; Imber, Brandon S; Wijetunga, N Ari; Goglia, Alexander G; Zhang, Zhigang; Zheng, Junting; Baser, Raymond; Bernstein, Ashley; Kratochvil, Leah; Xiao, Julie; Hattangadi-Gluth, Jona; Miller, Alexandra M; Wilcox, Jessica A; Betof Warner, Allison; Yu, Helena; Kris, Mark G; Seidman, Andrew D; Powell, Simon N; Boire, Adrienne

Advances in the understanding and therapeutic manipulation of cancer immune responsiveness: a Society for Immunotherapy of Cancer (SITC) review

癌症免疫反应的理解和治疗调控进展:癌症免疫治疗学会 (SITC) 综述

Cesano, Alessandra; Augustin, Ryan; Barrea, Luigi; Bedognetti, Davide; Bruno, Tullia C; Carturan, Alberto; Hammer, Christian; Ho, Winson S; Kather, Jakob Nikolas; Kirchhoff, Tomas; Lu, Rongze O; McQuade, Jennifer; Najjar, Yana G; Pietrobon, Violena; Ruella, Marco; Shen, Rhine; Soldati, Laura; Spencer, Christine; Betof Warner, Allison; Warren, Sarah; Ziv, Elad; Marincola, Francesco M

Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitors

基于共识的免疫检查点抑制剂内分泌免疫相关不良事件疾病定义

Zhu, Ling; Cheung, Yee-Ming M; Chiang, Cherie; Gallagher, Emily J; Hamnvik, Ole-Petter R; Mammen, Jennifer; Quandt, Zoe; Jones, Renisha; McDunn, Jon; Al-Bahadili, Huda; Angell, Trevor; Bancos, Irina; Betof Warner, Allison; Blackwell, Susan; Calabrese, Cassandra; Cho, Tracey A; Dougan, Michael; Ferreira, Michelle; Funchain, Pauline; Herndon, Justine; Johnson, Douglas B; Kennedy, Randol; Kheterpal, Meenal; Khouri, Michel; Lechner, Melissa G; Lim, Annette M; Markova, Alina; Meara, Alexa; Overton, Laura; Perdigoto, Ana Luisa; Sachithanandan, Nirupa; Sharon, Elad; Spain, Lavinia; Tsai, Katy; Yarchoan, Mark; Reynolds, Kerry L; Shariff, Afreen

Role of high-dose interleukin-2 for melanoma in the age of cellular therapy

在细胞疗法时代,高剂量白细胞介素-2在黑色素瘤治疗中的作用

Buchbinder, Elizabeth; Lotze, Michael T; Margolin, Kim A; Amaria, Rodabe; Sarnaik, Amod; Seery, Virginia; Eroglu, Zeynep; Khaddour, Karam; Betof Warner, Allison; Kluger, Harriet M; Sznol, Mario; Atkins, Michael B; Mcdermott, David F; Silk, Ann W

Proceedings of the seventh annual Women in Melanoma Conference

第七届年度女性黑色素瘤大会论文集

Najjar, Yana G; Orloff, Marlana; Mitchell, Tara C; Bowles, Tawnya L; Betof Warner, Allison; Bollin, Kathryn; Chandra, Sunandana; Cohen, Justine V; Eroglu, Zeynep; Funchain, Pauline; Gaughan, Elizabeth; Glitza Oliva, Isabella; Hsu, Sherry; Hu-Lieskovan, Siwen; Kennedy, Lucy Boyce; Truong, Thach-Giao; McKean, Meredith; Mehnert, Janice; Moon, Helen; Tsai, Katy K; Wilson, Melissa; Tran, Thuy; Buchbinder, Elizabeth I; Fecher, Leslie A; Guild, Samantha; Patel, Sapna P

Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy

肿瘤浸润淋巴细胞疗法管理和最佳实践的专家共识指南

Betof Warner, Allison; Hamid, Omid; Komanduri, Krishna; Amaria, Rodabe; Butler, Marcus O; Haanen, John; Nikiforow, Sarah; Puzanov, Igor; Sarnaik, Amod; Bishop, Michael R; Schoenfeld, Adam J

Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy

定义D-irAEs:基于共识的免疫检查点抑制剂治疗引起的皮肤不良事件诊断疾病定义

Chen, Steven T; Semenov, Yevgeniy R; Alloo, Allireza; Bach, Daniel Q; Betof Warner, Allison; Bougrine, Amina; Burton, Leeann; Cappelli, Laura C; Castells, Mariana; Cohen, Justine; Dewan, Anna K; Fadden, Riley; Guggina, Lauren; Hegde, Aparna; Huang, Victor; Johnson, Douglas B; Kaffenberger, Benjamin; Kroshinsky, Daniela; Kwatra, Shawn; Kwong, Bernice; Lacouture, Mario E; Larocca, Cecilia; Leventhal, Jonathan; Markova, Alina; McDunn, Jon; Mooradian, Meghan J; Naidoo, Jarushka; Choi, Jennifer; Nambudiri, Vinod; Nelson, Caroline A; Patel, Anisha B; Pimkina, Julia; Rine, Johnathan; Rubin, Krista M; Sauder, Maxwell; Shaigany, Sheila; Shariff, Afreen; Sullivan, Ryan J; Zubiri, Leyre; Reynolds, Kerry L; LeBoeuf, Nicole R

Early On-Treatment Assessment of T Cells, Cytokines, and Tumor DNA with Adaptively Dosed Nivolumab + Ipilimumab: Final Results from the Phase 2 ADAPT-IT Study

采用自适应剂量纳武利尤单抗联合伊匹木单抗治疗早期评估T细胞、细胞因子和肿瘤DNA:2期ADAPT-IT研究的最终结果

James W Smithy ,Hannah L Kalvin ,Fiona D Ehrich ,Ronak Shah ,Matthew Adamow ,Vladislav Raber ,Collen A Maher ,Jenna Kleman ,Deborah A G McIntyre ,Alexander N Shoushtari ,Allison Betof Warner ,Margaret K Callahan ,Parisa Momtaz ,Omar Eton ,Suresh Nair ,Jedd D Wolchok ,Paul B Chapman ,Michael F Berger ,Katherine S Panageas ,Michael A Postow

Early On-Treatment Assessment of T Cells, Cytokines, and Tumor DNA with Adaptively Dosed Nivolumab + Ipilimumab: Final Results from the Phase 2 ADAPT-IT Study

采用自适应剂量纳武利尤单抗联合伊匹木单抗治疗早期评估T细胞、细胞因子和肿瘤DNA:2期ADAPT-IT研究的最终结果

James W Smithy,Hannah L Kalvin,Fiona D Ehrich,Ronak Shah,Matthew Adamow,Vladislav Raber,Collen A Maher,Jenna Kleman,Deborah A G McIntyre,Alexander N Shoushtari,Allison Betof Warner,Margaret K Callahan,Parisa Momtaz,Omar Eton,Suresh Nair,Jedd D Wolchok,Paul B Chapman,Michael F Berger,Katherine S Panageas,Michael A Postow